VLVelemir S. Lavrinenko

Velemir S. Lavrinenko

*This is an algorithmically generated author record based on publicly available information.

Velemir S. Lavrinenko has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Stability-Weighted Combined Map for Cell Painting Across Regular and Prolonged Incubation

    by Velemir Lavrinenko, Ilona Donskaya, Vladimir Popov, Ekaterina Litau, Varvara Petrova, Kamila Valetdinova, Mikhail Trofimov, Alena Shurova, Daria Danilenko, Dmitry Lioznov, et al.

    Cell Painting screens usually profile compounds at a single fixed endpoint. Many drug responses, however, develop over days, and compounds whose phenotypes are weak or still forming at the chosen endpoint give unstable profiles that move between clusters in repeated experiments and blur the phenotypic map. We profiled 53 small molecules in HCT116 cells after 48 h and 8 days of exposure, each in two independent iterations, and represented every compound by the window in which its replicate profiles were more stable. The resulting stability-weighted Combined map separated phenotypic groups more clearly than either single window (silhouette score of the modal partition 0.360 versus 0.227 and 0.292). This gain exceeded random window assignment (p = 0.002), also under analysis parameters chosen without the Combined dataset (p = 0.001). The number of compounds with inconsistent cluster assignment between iterations decreased (6 versus 16 and 13 of 53), although less consistently across analysis settings. The approach distinguishes compounds whose phenotypes are captured reproducibly at 48 h, compounds captured more reproducibly at 8 days, and a convergent group for which both windows give similar profiles. It offers a practical way to add a prolonged exposure window to phenotypic screens and to prioritize compounds for follow-up.

  • Open Access

    Cell Painting Identifies Phenotypic Clusters Associated with Anticancer Drug Responses in OVCAR-3 Ovarian Cancer Cells

    by Vladimir E. Popov, Velemir S. Lavrinenko, Ekaterina V. Litau, Alena A. Shurova, Mikhail A. Trofimov, Daria M. Danilenko, Dmitry A. Lioznov, Ramziya G. Kiyamova, Stanislav F. Tyazhelnikov

    Cell Painting is a high-content imaging approach that enables systematic characterization of cellular responses to chemical perturbations through quantitative morphological profiling. Although this methodology has been widely applied in drug discovery and functional genomics, ovarian cancer models remain comparatively underrepresented in Cell Painting studies. In the present work, we established a Cell Painting workflow for OVCAR-3 ovarian cancer cells and applied it to the phenotypic profiling of 54 anticancer compounds representing diverse mechanisms of action. Cells were exposed to compounds under short- and prolonged-treatment conditions, followed by multiplex fluorescent staining, high-content imaging, feature extraction using CellProfiler, and computational analysis of the resulting morphological profiles. Profiles obtained at the two treatment durations were analyzed separately. For each compound, the treatment condition showing greater within-compound consistency in PCA space was additionally retained to construct a combined dataset. Morphological relationships were explored using Pearson correlation analysis, dimensionality reduction, and unsupervised clustering. Morphological profiles showed reproducible relationships among compounds. Compounds with related mechanisms showed greater morphological similarity than expected by chance, although substantial within-class heterogeneity remained. Statistically significant cluster enrichment was observed for microtubule-targeting agents and topoisomerase inhibitors, whereas other mechanism-related patterns were incomplete. Among the evaluated clustering approaches, Leiden and agglomerative clustering produced similar separation of the Combined dataset, with silhouette scores of 0.486 and 0.482, respectively. Cell Painting identified mechanism-associated but heterogeneous morphological responses in OVCAR-3 cells. The results support the use of this model for exploratory phenotypic profiling while highlighting the influence of exposure conditions and the limited ability of morphology alone to recover annotated molecular mechanisms.


  • Open Access

    Visualization, Data Extraction, and Multiparametric Analysis of 3D Pancreatic and Colorectal Cancer Cell Lines for High-Throughput Screening

    by Mikhail A. Trofimov, Ilya P. Bulatov, Velemir S. Lavrinenko, Vladimir E. Popov, Varvara S. Petrova, Anton S. Bukatin, Stanislav F. Tyazhelnikov

    Background: Three-dimensional (3D) cancer models are currently essential tools in high-throughput screening (HTS), serving as a bridge between in vitro and in vivo approaches during drug development. Even though spheroids offer many advantages over 2D cultures, analyzing 3D cultures with heterogeneous morphology remains challenging due to the lack of standardized visualization techniques and multiparameter analysis. Methods: In this work, an optimized CellProfiler pipeline and a Python algorithm for weighting morphological features are used to visualize, extract, and analyze morphological data from spheroids derived from colorectal and pancreatic cancer cell lines with diverse morphologies (HCT116, LoVo, PANC-1, and CFPAC-1). Results: We developed a feature weighting process that combines multiple morphological parameters into a single metric using principal component analysis (PCA). There is a strong correlation between this process and a standard Alamar Blue proliferation assay (r = 0.89, ρ = 0.91, p < 0.001). Using this method, we were able to ascertain the IC50 values of substances that did not produce results in cell lines with heterogeneous morphology (LoVo and CFPAC-1) using a standard proliferation assay. Conclusions: By removing the need for tracer dyes, the resulting methodology may lower costs while accelerating preclinical drug development through informative multiparameter analysis of compound efficacy.

  • Open Access

    Phenotypic profiling of small molecules using cell painting assay in HCT116 colorectal cancer cells

    by Velemir Lavrinenko, Ilona Donskaya, Vladimir Popov, Ekaterina Litau, Varvara Petrova, Stanislav Tyazhelnikov

    Understanding how small molecules affect cellular morphology is essential for exploring their mechanisms of action (MoA) and identifying new therapeutic candidates. In this study, the Cell Painting Assay (CPA) was used to profile 196 small molecules in HCT116 colorectal cancer cells. By applying t-distributed stochastic neighbor embedding (t-SNE) followed by density-based clustering, 18 distinct phenotypic clusters were identified based on similarities in the quantitative morphological profiles generated from Cell Painting data. Although it was initially hypothesized that clustering would reflect known MoAs, most clusters showed only partial overlap with target-based classifications. Instead, compounds from different MoA classes converged on similar cellular phenotypes, suggesting common downstream effects or shared stress responses. Notably, compounds affecting DNA replication, mitosis, or transcriptional control appeared across multiple clusters, indicating functional diversity within morphologically similar groups. Clusters enriched with mTOR/PI3K inhibitors, spindle poisons, or transcriptional CDK blockers exhibited well-defined phenotypes, supporting the robustness of the assay. In contrast, compounds inducing more subtle phenotypes formed distinct micro-clusters, highlighting the method’s sensitivity. Overall, this study demonstrates that CPA can capture convergent phenotypic signatures that extend beyond target-based classification. These findings underscore the value of phenotype-driven screening for the functional annotation of chemical compounds and may help uncover unexpected relationships among molecules with diverse biological activities.